The PIONEER 3 and 4 studies demonstrated the effectiveness of Rybelsus in reducing the Hb a1c of people with Type 2 diabetes. Rybelsus was shown to be more effective than liraglutide in the PIONEER 3 study, and more effective than the Januvia in the PIONEER 4 study.